0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Join our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessBackground. Cytoadherence and sequestration of erythrocytes containing mature stages of Plasmodium falciparum are central to the pathogenesis of severe malaria. The oral anthelminthic drug levamisole inhibits cytoadherence in vitro and reduces sequestration of late-stage parasites in uncomplicated falciparum malaria treated with quinine.
Richard J. Maude, Kamolrat Silamut, Katherine Plewes, Prakaykaew Charunwatthana, May Ho, M. Abul Faiz, Ridwanur Rahman, Md Amir Hossain, Mahtab Uddin Hassan, Emran Bin Yunus, Gofranul Hoque, Faridul Islam, Aniruddha Ghose, Josh Hanson, Joël Schlatter, Rachel Lacey, Alison Eastaugh, Joel Tärning, Sue J. Lee, Sir Nicholas White, Kesinee Chotivanich, Nicholas Day, Arjen M. Dondorp (2013). Randomized Controlled Trial of Levamisole Hydrochloride as Adjunctive Therapy in Severe Falciparum Malaria With High Parasitemia. The Journal of Infectious Diseases, 209(1), pp. 120-129, DOI: 10.1093/infdis/jit410.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2013
Authors
23
Datasets
0
Total Files
0
Language
English
Journal
The Journal of Infectious Diseases
DOI
10.1093/infdis/jit410
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free AccessYes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
